| 237 / Čes. slov. Farm. 2025;74(4):230-237 / ČESKÁ A SLOVENSKÁ FARMACIE www.csfarmacie.cz PŘEHLEDOVÉ PRÁCE Role farmaceuta v managementu antikoagulační terapie warfarinem – přehled literatury 24. Faircloth JM, Miner KM, Alsaied T, et al. Time in therapeutic range as a marker for thrombotic and bleeding outcomes in Fontan patients. J Thromb Thrombolysis. 2017 Jul;44(1):38-47. 25. Cryder BT, Felczak MA, Darkwa A, et al. Transition of stable patients from traditional anticoagulation clinic services to telephonic management. Int J Clin Pharm. 2017 Jun;39(3):569-572. 26. Elewa H, Jalali F, Khudair N, et al. Evaluation of pharmacist-based compared to doctor-based anticoagulation management in Qatar. J Eval Clin Pract. 2016 Jun;22(3):433-8. 27. Bereznicki LR, van Tienen EC, Stafford A. Home medicines reviews in Australian war veterans taking warfarin do not influence international normalised ratio control. Intern Med J. 2016 Mar;46(3):288-94. 28. Biszewski M, Nitzki-George D, Zhou Y. Comparison of warfarin time in the therapeutic range at a pharmacist-run anticoagulation clinic and the RE-LY trial. Am J Health Syst Pharm. 2015 Apr 1;72(7):557-62. 29. Modi RA, McGwin G, Westfall AO, et al. Venous thromboembolism among HIV-positive patients and anticoagulation clinic outcomes integrated within the HIV primary care setting. Int J STD AIDS. 2015 Oct;26(12):870-8. 30. Gupta V, Kogut SJ, Thompson S. Evaluation of differences in percentage of international normalized ratios in range between pharmacist-led and physician-led anticoagulation management services. J Pharm Pract. 2015 Jun;28(3):249-55. 31. Liu X, Xiao Q, Li Y, et al. Effect of post-discharge pharmacist-led follow-up on drug treatment in patients with deep venous thrombosis in primary hospitals in China. Pak J Pharm Sci. 2022 May;35(3):785-791. 32. Falamić S, Lucijanić M, Ortner-Hadžiabdić M, et al. Pharmacists' interventions improve health-related quality of life of rural older person on warfarin: a randomized controlled trial. Sci Rep. 2021 Nov 9;11(1):21897. 33. Falamić S, Lucijanić M, Ortner-Hadžiabdić M, et al. Pharmacists' influence on adverse reactions to warfarin: a randomised controlled trial in elderly rural patients. Int J Clin Pharm. 2019 Oct;41(5):1166-1173. 34. Heinrich K, Sanchez K, Hui C, et al. Impact of an electronic medium delivery of warfarin education in a low income, minority outpatient population: a pilot intervention study. BMC Public Health. 2019 Aug 5;19(1):1050. 35. Falamić S, Lucijanić M, Hadžiabdić MO, et al. Pharmacist's interventions improve time in therapeutic range of elderly rural patients on warfarin therapy: a randomized trial. Int J Clin Pharm. 2018 Oct;40(5):1078-1085. 36. Choumane NS, Malaeb DN, Malaeb B, et al. A multicenter, prospective study evaluating the impact of the clinical pharmacist-physician counselling on warfarin therapy management in Lebanon. BMC Health Serv Res. 2018 Feb 1;18(1):80. 37. Gallagher J, Mc Carthy S, Woods N, et al. Economic evaluation of a randomized controlled trial of pharmacist-supervized patient self-testing of warfarin therapy. J Clin Pharm Ther. 2015 Feb;40(1):14-9. 38. Harrison J, Shaw JP, Harrison JE. Anticoagulation management by community pharmacists in New Zealand: an evaluation of a collaborative model in primary care. Int J Pharm Pract. 2015 Jun;23(3):173-81. 39. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009 Sep 17;361(12):1139-51. 40. Saokaew S, Permsuwan U, Chaiyakunapruk N, et al. Effectiveness of pharmacist-participated warfarin therapy management: a systematic review and meta-analysis. J Thromb Haemost. 2010 Nov;8(11):2418-27. 41. Omer AAA, Kusuma IY, Csupor D, et al. Outcomes of pharmacist-led patient education on oral anticoagulant therapy: A scoping review. Res Social Adm Pharm. 2025 Jun;21(6):463-479. 42. Kefale B, Peterson GM, Mirkazemi C, et al. The effect of pharmacist-led interventions on the appropriateness and clinical outcomes of anticoagulant therapy: a systematic review and meta-analysis. Eur Heart J Qual Care Clin Outcomes. 2024 Sep 13;10(6):488-506. 43. Entezari-Maleki T, Dousti S, Hamishehkar H, et al. A systematic review on comparing 2 common models for management of warfarin therapy; pharmacist-led service versus usual medical care. J Clin Pharmacol. 2016 Jan;56(1):24-38. 44. Hou K, Yang H, Ye Z, et al. Effectiveness of Pharmacist-led Anticoagulation Management on Clinical Outcomes: A Systematic Review and Meta-Analysis. J Pharm Pharm Sci. 2017;20(1):378-396. 45. Zhou S, Sheng XY, Xiang Q, et al. Comparing the effectiveness of pharmacist-managed warfarin anticoagulation with other models: a systematic review and meta-analysis. J Clin Pharm Ther. 2016 Dec;41(6):602-611. 46. Lyons I, Barber N, Raynor DK, et al. The Medicines Advice Service Evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence. BMJ Qual Saf. 2016 Oct;25(10):759-69. 47. Mohammed MA, Moles RJ, Chen TF. Impact of Pharmaceutical Care Interventions on Health-Related Quality-of-Life Outcomes: A Systematic Review and Meta-analysis. Ann Pharmacother. 2016 Oct;50(10):862-81. 48. Netuka I, Ivák P, Tučanová Z, et al. Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study. J Heart Lung Transplant. 2018 May;37(5):579-586. Super, už mám předplaceno. A dostala jsem navíc: 20% slevu na kongresy* 4× časopis Česká a slovenská farmacie 4 body ČLnK s každým číslem (po vyplnění autodidaktického testu) Přístup do archivu časopisu on-line ale kde a jak? ČASOPIS Česká a slovenská farmacie OBJEDNÁVEJTE: www.csfarmacie.cz predplatne@solen.cz CENA PŘEDPLATNÉHO NA ROK 2026 1 050 Kč
RkJQdWJsaXNoZXIy NDA4Mjc=